Workflow
更大力度培育耐心资本推动科技与产业创新融合发展
Shang Hai Zheng Quan Bao·2025-06-24 18:12

Group 1 - The core viewpoint emphasizes the need for cultivating patient capital to bridge the funding gap and cycle mismatch in the integration of technological and industrial innovation [1][2] - The China Securities Regulatory Commission (CSRC) chairman highlighted the importance of long-term capital in supporting the sustainable growth of technology enterprises [1][4] - Private equity funds play a crucial role in nurturing patient capital, as they align with the growth patterns of technology innovation and cover the financing needs throughout the lifecycle of tech companies [1][2] Group 2 - Recent data shows that private equity and venture capital funds have invested in 90% of companies listed on the Sci-Tech Innovation Board and over half of those on the Growth Enterprise Market [2] - As of April 2025, there are nearly 20,000 private fund managers managing over 140,000 funds with a total scale of 20 trillion yuan [2] - The CSRC plans to focus on enhancing the fundraising, investment, management, and exit processes of private equity funds to attract more long-term capital [2][3] Group 3 - The development of technology innovation indices can provide a safety net and value anchor for patient capital by accurately selecting technology assets with long-term growth potential [3] - The introduction of public funds with technology attributes can transform fragmented and short-term market funds into long-term capital supporting technological innovation [3] - Since the launch of the "Eight Measures for the Sci-Tech Innovation Board," multiple technology innovation indices have been released, significantly contributing to attracting incremental capital into the market [3][4] Group 4 - The continuous nurturing of patient capital is essential for the growth of technology and industrial innovation, with expectations for improved policy environments and diversified funding sources [4] - The capital market is anticipated to accelerate the cultivation of patient and long-term capital to support the growth of technology enterprises and the rise of emerging industries [4]